#Tabrecta - Twitter Hashtag

over 3 years ago

Will Tabrecta cure lung cancer? #Tabrecta (capmatinib) is an oral tablet approved to treat adult patients with metastatic non-small cell lung cancer (#mNSCLC) with specific mutations (MET exon 14 skipping), as detected by an FDA-approved test. https://t.co/d8B1e0itDE

MedPipeline's tweet photo. Will Tabrecta cure lung cancer? #Tabrecta (capmatinib) is an oral tablet approved to treat adult patients with metastatic non-small cell lung cancer (#mNSCLC) with specific mutations (MET exon 14 skipping), as detected by an FDA-approved test. https://t.co/d8B1e0itDE https://t.co/UWf9NnFo3o

0

2

1

0

349

Cyclica @Cyclica

over 5 years ago

Thank you, @MaRSDD. In collaboration with our academic partners, we repurposed Capmatnib (#Tabrecta) to treat non-small #lungcancer patients as a novel #drug target for #COVID19. Read the #pressrelease here - https://t.co/OfKKj1g1cF #drugdiscovery #machinelearning

MaRS

@MaRSDD

over 5 years ago

"@Cyclica isn’t just tackling the #COVID19 problem from a different direction — it hopes to surround it with a full-stack artificial intelligence approach to drug repurposing enlisting several research organizations and universities." https://t.co/bpoewf8ffn

0

2

1

0

5

0

Laura Greco @lgreco_ny

almost 6 years ago

T3: Huge one is capmatinib, #tabrecta for METexon14, also useful for metamp @METCrusaders

1

7

0

Frank Vinluan @frankvinluan

over 6 years ago

#Selpercatinib's approval is the 2nd this week covering a #cancer drug targeting a particular genetic aberration. The FDA on Wed. approved @Novartis drug #capmatinib (#Tabrecta) for #nonsmallcelllungcancer driven by mutations of the MET gene https://t.co/0Wix6t5ySc $NVS

0

2

0

Frank Vinluan @frankvinluan

over 6 years ago

In #cancer drug news, the FDA granted accelerated approval to @Novartis drug #capmatinib (#Tabrecta) for #NSCLC w/ a certain genetic mutation. $NVS licensed rights to the drug from @Incyte https://t.co/0Wix6t5ySc $INCY

0

1

2

0

1stOncology @1stOncology

over 6 years ago

#FoundationMedicine Receives FDA Approval for #FoundationOneCDx as the #CompanionDiagnostic for #Tabrecta™ (#Capmatinib), the Only #FDA-Approved #METInhibitor for Patients With Metastatic #NonSmallCellLungCancer With #METex14 https://t.co/LceIX6Pt54

0

2

1

0

Liseth M Parra, PhD @lisethmparra

over 6 years ago

The #FDA approves first targeted therapy to treat an aggressive form of #NSCLC with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping) that has spread to other parts of the body #Tabrecta (capmatinib) $NVS https://t.co/xTCV03KaoI

0

1

0

Dr. Estela Rodriguez

@Latinamd

over 6 years ago

FDA Approves #Tabrecta , the First Targeted Drug for Patients with Non-Small Cell Lung Cancer and #MET exon 14. Mutation found in 3-4% of #lungcancer ORR 41%, approved for first and second line #lcsm https://t.co/7tNDIZza6H

0

6

2

0

Top Tweets for #Tabrecta

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users